Cite
HARVARD Citation
Ligumsky, H. et al. (2022). Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer. Lancet oncology. 23 (2), pp. 193-195. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Ligumsky, H. et al. (2022). Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer. Lancet oncology. 23 (2), pp. 193-195. [Online].